Thursday, April 8, 2010

StockProfiler.US: Penny Stock News for Thursday: Bion Environmental Technologies, Inc. & Transdel Pharmaceuticals, Inc.



NEW YORK, April 8, 2010 -- Bion Environmental Technologies, Inc. (OTCBB: BNET) announced today that it recently closed an offering of its Series C Convertible Preferred Shares.

Bion Environmental Technologies, Inc. closed at $2.27 Wednesday, trading 1,500 shares.

Bion Announces Private Placement Closed

About Bion

Bion Environmental Technologies has provided environmental treatment solutions to the agriculture and livestock industry since 1990. Bion's patented next-generation technology provides a unique comprehensive treatment of livestock waste that achieves substantial reductions in nitrogen and phosphorus, ammonia, greenhouse and other gases, and pathogens. Bion's process simultaneously recovers cellulosic biomass from the waste stream to produce renewable energy. For more information, see Bion's website: biontech.com.

For additional
penny stock news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

LA JOLLA, Calif., April 8, 2010 -- Transdel Pharmaceuticals, Inc. (
OTCBB: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, today announced that it has completed a private debt financing of $1 million.

Transdel Pharmaceuticals, Inc. closed at $1.00 Wednesday, trading 5,000 shares.

Transdel Pharmaceuticals Closes $1 Million Debt Financing

About Transdel Pharmaceuticals, Inc.

Transdel Pharmaceuticals, Inc. (
OTCBB: TDLP) is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company's innovative-patented Transdel™ cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier. Ketotransdel®, the Company's lead pain product, has completed a Phase 3 clinical trial and utilizes the Transdel™ technology to deliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug through the skin directly into the underlying tissues where the drug exerts its well-known anti-inflammatory and analgesic effects. The Company intends to leverage its Transdel™ platform technology to expand and create a portfolio of topical products for a variety of indications. The Company is actively pursuing partnerships with companies to expand its product portfolio for pharmaceutical and cosmetic/cosmeceutical products. For more information, please visit transdelpharma.com.

For additional
penny stock news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

StockProfiler.US Announcement!

Membership with access to enhanced
stock investing tools is now FREE! Claim yours at http://stockprofiler.us/index.php?action=main.register

Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at
http://twitter.com/StockProfilerUS

View free
penny stock company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS

-------------------------------------------

About StockProfiler.US:

StockProfiler.US is a media source for publicly traded
penny stock companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

Call us at (603) 424-4420 or email
info@stockprofiler.us

-------------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to:
http://www.stockprofiler.us, http://www.associatesfortune.com, http://www.fastmoneytalk.com, http://www.markettelegraph.com, http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to
http://stockprofiler.us/?action=main.disclaimer

-------------------------------------------

Keywords: penny stock, penny stock news, penny stock alerts, penny stock updates, penny stock news updates, penny stock profile

No comments:

Post a Comment